Skip to main content
Equibles

Frazier Life Sciences Management, L.P.

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1892134 PALO ALTO, CA
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$36,386,409
+$4,372,122 QoQ
Shares Held
1,438,198
0.0% QoQ
Ownership
0.835%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#20
of 354 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Frazier Life Sciences Management, L.P. holds $4,497,017,185 across 37 Biotechnology names. ACAD ranks #23 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MIRM
Mirum Pharmaceuticals, Inc.
 7,679,684 $899,060,605
2 NAMS
NewAmsterdam Pharma Co N.V.
 18,589,235 $623,725,004
3 ERAS
Erasca, Inc.
 24,975,188 $457,545,444
4 MBX
MBX Biosciences, Inc.
 6,652,013 $367,191,117
5 ARQT
Arcutis Biotherapeutics, Inc.
 9,874,511 $258,909,678
6 TRVI
Trevi Therapeutics, Inc.
 9,939,447 $185,370,686
7 KRYS
Krystal Biotech, Inc.
 481,307 $178,887,372
8 MAZE
Maze Therapeutics, Inc.
 5,032,915 $150,182,183

All Filings in ACAD

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $36,386,409 1,438,198
2026-03-31 $32,014,287 1,438,198
2025-12-31 $34,648,158 1,297,198
2025-09-30 $13,099,281 613,837
2025-03-31 $7,812,314 470,338
2024-12-31 $8,630,702 470,338
2024-09-30 $7,233,798 470,338
2024-06-30 $7,642,992 470,338
2024-03-31 $8,696,549 470,338
2023-12-31 $22,885,011 730,917
2023-09-30 $13,147,893 630,897
2023-06-30 $20,533,245 857,338
2023-03-31 $16,135,101 857,338
2022-12-31 $13,648,820 857,338
2022-09-30 $14,026,049 857,338